Remicade News
Most Popular Remicade Story
J&J wants a piece of Merck/Schering action
We hear Johnson & Johnson is twisting a few arms at Schering-Plough. The Financial Times quotes sources close to the talks, saying that J&J is prepping for a legal challenge to Schering's Read more...
Latest Headlines
- April 15, 2011
- February 11, 2011
- October 15, 2010
- September 8, 2010
- November 13, 2009
- August 5, 2009
- May 28, 2009
- May 21, 2009
- April 24, 2009
- March 30, 2009
- October 24, 2008
- September 5, 2008
- July 21, 2008
- June 5, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
